MX2022000899A - Stable pharmaceutical compositions with enhanced solubility comprising the combination of a cox-2 inhibitor and an anthraquinone derivative.
- Google Patents
Stable pharmaceutical compositions with enhanced solubility comprising the combination of a cox-2 inhibitor and an anthraquinone derivative.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Liomont S A De C VfiledCriticalLaboratorios Liomont S A De C V
Priority to MX2022000899ApriorityCriticalpatent/MX2022000899A/en
Publication of MX2022000899ApublicationCriticalpatent/MX2022000899A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The present invention relates to a pharmaceutical composition containing a COX-2 inhibitor and an anthraquinone derivative, designed for a single-dose administration. Also, it aims to improve the solubility of the active ingredients without affecting their stability or compatibility between them and the other components. Further, said composition is useful for treating the pain and inflammation of osteoarthritis, rheumatoid arthritis, degenerative joint disease, and related diseases.
MX2022000899A2022-01-212022-01-21Stable pharmaceutical compositions with enhanced solubility comprising the combination of a cox-2 inhibitor and an anthraquinone derivative.
MX2022000899A
(en)
Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providing enhanced therapeutic activity
Liquid or paste compositions intended to provide elements essential for the synthesis and formation of proteoglycans, in particular, for the treatment of cartilage degradation